Fulminant Mixed Cardiac Allograft Rejection with Atypical Biopsy Findings and Negative MMDx Treated with VA-ECMO, Bortezomib, Eculizumab, and Daratumumab
Year: 2025
Type: article
Authors: P. Narasimmaraj, P. VanderLaan, Y. Li, I. Guleria, P. Quintero, R. Vesper, L. Fleming, M. Sabe, E. Grandin, J. Ho, A. Garan, M. Kai, Y. Tsukioka, R. Sriwattanakomen
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409805662
